Enjoy complimentary customisation on priority with our Enterprise License!
The epinephrine autoinjector market size is forecast to increase by USDUSD 2.44 billion at a CAGR of 10.59% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of severe allergic reactions. Innovative technologies, such as needle-free injectors and needle free drug , are gaining acceptance as they offer prompt intervention and increased convenience for individuals with allergies. The market is witnessing frequent product launches in response to the growing demand for effective and user-friendly solutions. However, challenges persist, including product recalls and regulatory issues, which can impact market growth. As autoinjector awareness of allergies continues to increase, the market is expected to continue its expansion, providing essential treatments for those in need.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.